Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls
https://pubmed.ncbi.nlm.nih.gov/19188531/Actively Recruiting
Led by Fundación de Investigación Biomédica - Hospital Universitario de La Princesa · Updated on 2026-09-02
124
Participants Needed
5
Research Sites
4 weeks
Total Duration
Researchers are studying the effects of physical exercise on patients diagnosed with Major Depressive Disorder MDD. The trial aims to understand the anti-inflammatory, oxidative stress, and brain mechanisms involved in the antidepressant effects of exercise, as well as the effectiveness of a physical exercise program for MDD patients in real-life conditions. It compares an exercise intervention added to usual antidepressant treatment with standard treatment alone. Participants in the exercise group will follow a 12-week program consisting of daily walking with step goals monitored by an activity band, plus two weekly 60-minute supervised online group sessions combining aerobic and strength exercises. The control group will continue standard antidepressant treatment without changing their usual physical activity. The study includes baseline, 12-week, and one-year follow-up assessments. Throughout the study, participants will undergo clinical evaluations, brain imaging, inflammatory and oxidative stress biomarker testing, cognitive and functioning assessments, and physical fitness measures. Daily activity and sleep will be tracked using wearable devices. Researchers will monitor symptoms and brain changes before, during, and after the intervention to assess the lasting effects of exercise combined with standard treatment.
CONDITIONS
Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders
J
Javier Gómez Cumplido, PT, MSc
P
Pilar López García, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Lead Sponsor
Hospital Universitario La Paz
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants in the exercise group will follow a 12-week physical exercise program alongside their usual antidepressant treatment, including daily walking with step goals and twice-weekly supervised online aerobic and strength sessions. The control group will continue standard antidepressant treatment without changing physical activity.
Twice-weekly supervised exercise sessions plus daily step monitoring
Duration - Up to 1 year after intervention start
Participants will be assessed one year after starting the intervention to evaluate long-term effects on depressive symptoms, brain changes, cognitive performance, and functioning.
1 follow-up visit
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
M Bryant Howren, Donald M Lamkin, Jerry Suls
https://pubmed.ncbi.nlm.nih.gov/19188531/Jesper Krogh, Bengt Saltin, Christian Gluud...
https://pubmed.ncbi.nlm.nih.gov/19573478/Rod K Dishman, Hans-Rudolf Berthoud, Frank W Booth...
https://pubmed.ncbi.nlm.nih.gov/16648603/Andrew H Miller, Charles L Raison
https://pubmed.ncbi.nlm.nih.gov/26711676/Chengchao Zuo, Huan Cao, Yu Song...
https://pubmed.ncbi.nlm.nih.gov/36335763/Aaron J Done, Tinna Traustadóttir
https://pubmed.ncbi.nlm.nih.gov/27770706/George M Slavich, Michael R Irwin
https://pubmed.ncbi.nlm.nih.gov/24417575/Neha Mathur, Bente Klarlund Pedersen
https://pubmed.ncbi.nlm.nih.gov/19148295/A John Rush, Madhukar H Trivedi, Stephen R Wisniewski...
https://pubmed.ncbi.nlm.nih.gov/17074942/Yekta Dowlati, Nathan Herrmann, Walter Swardfager...
https://pubmed.ncbi.nlm.nih.gov/20015486/Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Lead Sponsor
Hospital Universitario La Paz
Collaborating Sponsor